130 results on '"Tziotzios, Christos"'
Search Results
2. Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
3. Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
4. Genome-wide meta-analysis implicates variation affecting mast cell biology in urticaria
5. Physical urticaria: Clinical features, pathogenesis, diagnostic work-up, and management
6. Molecular exploration of frontal fibrosing alopecia
7. Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia.
8. Systematic review of the clinical characteristics and natural history of solar urticaria
9. A novel heterozygous missense variant in ribosomal protein L21 associated with familial hypotrichosis simplex.
10. Shared Genetic Risk Variants in Both Male and Female Frontal Fibrosing Alopecia
11. 723 - Efficacy of ritlecitinib in patients with alopecia areata by extent of hair loss at baseline: post hoc analysis of the phase 3 long-term ALLEGRO-LT study.
12. Non-hormone treatment of menopause symptoms: Hair loss is an important symptom of the menopause
13. Familial hypotrichosis simplex of the scalp associated with a novel heterozygous nonsense variant in CDSN.
14. Alopecia areata and risk of common infections: a population-based cohort study.
15. Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study.
16. Finasteride is of uncertain utility in treating frontal fibrosing alopecia
17. Familial frontal fibrosing alopecia
18. The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care.
19. 43117 Integrated safety analysis of ritlecitinib in adolescent patients with alopecia areata from the randomized, placebo-controlled ALLEGRO phase 2b/3 and ongoing open-label phase 3 ALLEGRO-LT studies
20. Pathogenesis of solar urticaria: Classic perspectives and emerging concepts.
21. Actinic lichen planopilaris: a new variant of lichen planopilaris triggered by ultraviolet radiation.
22. Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper.
23. Reply
24. Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics: Part II. Strategies to reduce scar formation after dermatologic procedures
25. Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics: Part I. The molecular basis of scar formation
26. Bilateral irreversible blindness in leukaemic meningitis: cause or cure?
27. A small left pupil and a headache
28. Perforin, COVID‐19 and a possible pathogenic auto‐inflammatory feedback loop.
29. Time Series Integrative Analysis of RNA Sequencing and MicroRNA Expression Data Reveals Key Biologic Wound Healing Pathways in Keloid-Prone Individuals
30. Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of Frontal Fibrosing Alopecia
31. Congenital Anonychia and Uncombable Hair Syndrome: Coinheritance of Homozygous Mutations in RSPO4 and PADI3
32. Contact allergy across the human lifespan
33. Lichen planus and lichenoid dermatoses: Conventional and emerging therapeutic strategies.
34. Lichen planus and lichenoid dermatoses: Clinical overview and molecular basis.
35. Dolly, human cloning, and bioethics
36. Frontal fibrosing alopecia: reflections and hypotheses on aetiology and pathogenesis.
37. Unravelling the genetic basis of contact allergy.
38. There is no proven association between sensitization to benzyl salicylate and frontal fibrosing alopecia.
39. Contact urticaria to non‐latex synthetic glove material: A case report.
40. Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA.
41. A True Positive Nasal Nodule
42. Frontal fibrosing alopecia should be renamed to lichen planopilaris of Kossard.
43. Nail lichen planus.
44. Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.
45. Hair loss is an important symptom of the menopause.
46. A Distracting Stroke and the Erythematous Flag
47. Hair loss is an important symptom of the menopause
48. lesson of the month (1)
49. Lifetime incidence and healthcare disparities in alopecia areata: A UK population-based cohort study.
50. Epidemiology, management and the associated burden of mental health illness, atopic and autoimmune conditions, and common infections in alopecia areata: protocol for an observational study series.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.